Nick Zagorski, Psych News, March 9, 2023. Drs. Igor Grant and Ziva Cooper comment on how the Medical Marijuana and Cannabidiol Research Expansion Act law will impact medical cannabis research. Read the article here.
The Center for Medicinal Cannabis Research is pleased to offer continuing medical education (CME) credits for select 2022 CMCR Symposium presentations. These modules were open for credit until February 2024 and are now closed.
Learners will need to create an account HERE to claim credits. If you are a UC San Diego or UC San Diego Health employee, please log in with your @ucsd.edu SSO credentials (do not use your health email account).
Once your account is created, you may browse CMCR Symposium accredited content HERE.
When you have completed the education click on POST-TEST to attest to having viewed all or some of the education and claim credit. Then click on SHOW RESULTS.
Click on MyCME or EVALUATION & CERTIFICATES to access and download certificates.
Accreditation
The University of California San Diego School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of California San Diego School of Medicine designates this Enduring Material activity for a maximum of 4.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAPA: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 4.00 hours of Category 1 credit for completing this program.
Nurses: For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credits™ issued by organizations accredited by the ACCME. For the purpose of relicensure, the California Board of Registered Nursing accepts AMA PRA Category 1 Credits™ (report up to 4.00 hours of credit and list "CME Category 1" as the provider number).
Pharmacists: The California Board of Pharmacy accepts as continuing education for pharmacists coursework which meets the standard of relevance to pharmacy practice and is accepted as continuing education by the Medical Board of California.
Psychologists: The California Board of Psychology recognizes and accepts AMA PRA Category 1 Credit(s)™ for license renewal. Psychologists outside of California should check with their state and local boards to ensure that ACCME accredited activities are acceptable for renewal.
Meredith Wadman, Science, December 2, 2022 The Medical Marijuana and Cannabidiol Research Expansion Act law makes new regulations to help researchers in the process of doing medical cannabis research. Read the article here.
Dr. Thomas Arkell, a research fellow at Swinburne University of Technology in Melbourne, Australia recently presented to CMCR investigators on the effects of THC and CBD on driving and cognition. His research aims to better understand how cannabis impacts driving and cognition, what factors modulate cannabis effects, and its potential as a therapeutic aid. Dr. Arkell conducted the first study evaluating the effects of THC with and without CBD on real world driving performance. He currently chairs the Cannabis and Driving Working Group for the International Council on Alcohol Drugs and Traffic Safety (ICADTS). See the ICADTS website for a series of fact sheets reviewing the scientific evidence on cannabis and driving.
On August 31, 2022 CMCR hosted a press conference organized by Representative Scott Peters of California to provide a briefing in regard to HR 8540, “Developing and Nationalizing Key Cannabis Research Act of 2022" that he and Representative Dave Joyce of Ohio are introducing. The Act envisions enhanced support for research into medicinal cannabis and the broader understanding of the impact of cannabis on public health by establishing a national research agenda, funding 10 national interdisciplinary centers of excellence on cannabis research, and shielding universities from legal threat if they acquire for study purposes medicinal cannabis products from dispensaries in states which it is legal to do so. In recognition of CMCR‘s national leadership role on medicinal cannabis research, Mr. Peters requested that CMCR host this press conference.
Scott Peters - Press Conference on new Federal Cannabis Research Legislation
Page 8 of 23